Samir Parekh, MBBS
Hematology-Oncology, Cancer (Oncology)
Dr. Samir Parekh, MD is Professor (with tenure) of Medicine (Hematology and Medical Oncology) and Oncological Sciences. He is the Director of Translational Research in Myeloma and co-leader of the Cancer Clinical Investigation program at The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. He is also a faculty member of the Icahn Genomics Institute.
Dr. Parekh's research focuses on the pathogenesis of hematological malignancies and development of individualized, precision-medicine therapies for these malignancies. His lab uses an integrated systems biology approach to study genome-wide methylation, gene expression and DNA sequence variation to understand pathogenesis, develop biomarkers and guide personalized therapy in B cell malignancies, particularly Multiple Myeloma and Non-Hodgkin's lymphoma.
Dr. Parekh has served on numerous review and advisory committees. He has successfully secured several federal and foundation grants and has authored multiple peer-reviewed publications.
- Mount Sinai Beth Israel
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
Computational Biology, Drug Resistance, Epigenetics, Lymphoma, Transcriptional Activation and Repression
Multi-Disciplinary Training Areas
Cancer Biology [CAB], Development Regeneration and Stem Cells [DRS], Pharmacology and Therapeutics Discovery [PTD]